Maximizing the success of biosimilar implementation

Rieke Alten^*, Max Weinbrecht-Mischkewitz

^*Corresponding author af dette arbejde

2 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Nature Reviews Rheumatology
Vol/bind	19
Udgave nummer	12
Sider (fra-til)	757-758
Antal sider	2
ISSN	1759-4790
DOI	https://doi.org/10.1038/s41584-023-01048-7
Status	Udgivet - nov. 2023
Udgivet eksternt	Ja

Adgang til dokumentet

@article{74b4eb1a61f04558ab823f48ed78a6ab,

title = "Maximizing the success of biosimilar implementation",

author = "Rieke Alten and Max Weinbrecht-Mischkewitz",

year = "2023",

month = nov,

doi = "10.1038/s41584-023-01048-7",

language = "English",

volume = "19",

pages = "757--758",

journal = "Nature Reviews Rheumatology",

issn = "1759-4790",

publisher = "Nature Publishing Group",

number = "12",

}

TY - JOUR

T1 - Maximizing the success of biosimilar implementation

AU - Alten, Rieke

AU - Weinbrecht-Mischkewitz, Max

PY - 2023/11

Y1 - 2023/11

UR - http://www.scopus.com/inward/record.url?scp=85175159875&partnerID=8YFLogxK

U2 - 10.1038/s41584-023-01048-7

DO - 10.1038/s41584-023-01048-7

M3 - Comment/debate

C2 - 37903917

AN - SCOPUS:85175159875

SN - 1759-4790

VL - 19

SP - 757

EP - 758

JO - Nature Reviews Rheumatology

JF - Nature Reviews Rheumatology

IS - 12

ER -